Loading organizations...
Cytoo is a contract research organization (CRO) based in Grenoble, France, that specializes in human muscle pathology modeling and comprehensive drug discovery services across all stages for the biotechnology and pharmaceutical sectors. The company develops proprietary cellular models and screening assays, including MyoScreen, OncoSpheres, Hepatocytes, and Renal Proximal Tubules, alongside micropattern chips and plates used for targeting muscular atrophy, oncology, and cardiology. Operating with a workforce of 27 employees, the business generates just under $5 million in annual revenue. Cytoo has raised $15.9 million in total funding across three rounds, including a recent $10 million investment, and shares board-level connections with notable technology and healthcare companies such as Eos Imaging, Withings, Sculpteo, and CleveXel Pharma. The organization was officially founded in 2008 by ESPCI professor and physicist Jacques Lewiner alongside Marc Le Bozec.
Cytoo has raised $14.0M across 2 funding rounds.
Cytoo has raised $14.0M in total across 2 funding rounds.
Cytoo has raised $14.0M in total across 2 funding rounds.
Cytoo's investors include Sham and Entrepreneurs Fund, Jacques Lewiner, Jacques Mallet, Auriga Partners.
Cytoo has raised $14.0M across 2 funding rounds. Most recently, it raised $9.3M Series C in November 2011.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 28, 2011 | $9.3M Series C | Sham And Entrepreneurs Fund | Jacques Lewiner, Jacques Mallet | Announced |
| Sep 30, 2009 | $4.7M Venture Round | Auriga Partners | Jacques Lewiner | Announced |
